- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A326030 | ₩111,100.00 | 6.1% | 10.7% | ₩8.7t | ₩123,357.14 | PE151.6x | E50.7% | n/a | ||
A009420 | ₩38,650.00 | 13.8% | -12.8% | ₩2.0t | ₩53,285.71 | PS14.6x | E67.8% | n/a | ||
A214450 | ₩262,500.00 | 2.3% | 139.7% | ₩2.7t | ₩282,750.00 | PE30.7x | E27.9% | 0.4% |
Page 1 of 1